Pulse Journal Club Active Debates Trending Explore Researchers

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Home Explore Journal Club Trending

⌘+K

Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer | Synapse

January 20, 2014Open Access

Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Our data provides valuable baseline information regarding the TGF-β pathway in pancreatic cancer, which can be utilized in targeted therapy clinical trials. High TGF-β1 plasma level, SMAD4 SNP or TGF-βR2/SMAD4 tumor protein expression may suggest a dependence on this pathway in patients with advanced pancreatic cancer.

Ask AI

Mark Helpful

Bookmark

Relay

View Full Paper

Ask AI

Mark Helpful

Bookmark

Relay

View Full Paper

Cite This Study

Javle et al. (Mon,) studied this question.

synapsesocial.com/papers/69d9566fc7f0c3ae80a3d0d4 https://doi.org/https://doi.org/10.1371/journal.pone.0085942

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A "Silent" Polymorphism in the <i>MDR</i> 1 Gene Changes Substrate Specificity2006 · 2,469 citations
2DPC4 gene in various tumor types.1996 · 676 citations
3Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression.1993 · 162 citations
4Risk Factors for Pancreatic Cancer: Case-Control Study2007 · 332 citations
5<i>DPC4</i> , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.11996 · 2,340 citations